Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.819 EUR | +2.89% | -1.33% | +14.87% |
19/04 | Novacyt: confident ahead of DHSC trial | CF |
19/04 | Novacyt expects court to dismiss application by UK DHSC | AN |
Sales 2021 | 95.78M 102M 8.54B | Sales 2022 | 21.04M 22.5M 1.88B | Capitalization | 76.79M 82.1M 6.85B |
---|---|---|---|---|---|
Net income 2021 | -9M -9.62M -803M | Net income 2022 | -25M -26.73M -2.23B | EV / Sales 2021 | 1.67 x |
Net cash position 2021 | 99.9M 107M 8.91B | Net cash position 2022 | 86.29M 92.27M 7.7B | EV / Sales 2022 | -0.45 x |
P/E ratio 2021 |
-26.3
x | P/E ratio 2022 |
-2.99
x | Employees | 120 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 96.8% |
Latest transcript on Novacyt
1 day | +2.89% | ||
1 week | -1.33% | ||
Current month | +58.41% | ||
1 month | +58.57% | ||
3 months | +47.57% | ||
6 months | +74.11% | ||
Current year | +14.87% |
Managers | Title | Age | Since |
---|---|---|---|
James McCarthy
CEO | Chief Executive Officer | 58 | 05/21/05 |
Steven Gibson
DFI | Director of Finance/CFO | 41 | 01/17/01 |
Paul Oladimeji
CTO | Chief Tech/Sci/R&D Officer | - | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Heath
BRD | Director/Board Member | 76 | 29/15/29 |
John Brown
BRD | Director/Board Member | 69 | 08/23/08 |
Lyn Rees
BRD | Director/Board Member | 51 | 08/23/08 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.819 | +2.89% | 159,483 |
25/24/25 | 0.796 | -5.24% | 131,739 |
24/24/24 | 0.84 | +3.70% | 294,239 |
23/24/23 | 0.81 | +3.85% | 341,386 |
22/24/22 | 0.78 | -6.02% | 634,794 |
Real-time Euronext Paris, April 26, 2024 at 08:58 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.87% | 61.68M | |
-28.51% | 925M | |
-20.60% | 128M | |
-7.82% | 67.46M | |
+6.64% | 60.58M | |
+0.60% | 51.45M |
- Stock Market
- Equities
- ALNOV Stock